Bristol-Myers Squibb BMY Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's total cost of revenue?
- Bristol-Myers Squibb (BMY) reported total cost of revenue of $3.42B in Q1 2026.
- How has Bristol-Myers Squibb's total cost of revenue changed year-over-year?
- Bristol-Myers Squibb's total cost of revenue increased by 12.8% year-over-year, from $3.03B to $3.42B.
- What is the long-term trend for Bristol-Myers Squibb's total cost of revenue?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's total cost of revenue has grown at a 8.8% compound annual growth rate (CAGR), from $9.94B to $13.94B.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.